Cell-mediated immunity in atherosclerosis

Current Opinion in Lipidology

Volumn 8, Issue 5, 1997, Pages 301-311

  Hansson, Göran K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; HEAT SHOCK PROTEIN; MARKER; METALLOPROTEINASE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; RECEPTOR; SCAVENGER;

ANTIBODY RESPONSE; APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; DISEASE ACTIVITY; ENDOTHELIUM CELL; ENZYME RELEASE; FEEDBACK SYSTEM; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MACROPHAGE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

ANIMALIA;

EID: 0030730605     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199710000-00009     Document Type: Review

References (110)

1. Hansson GK, Libby P: The role of the lymphocyte. In Atherosclerosis and Coronary Artery Disease. Edited by Fuster V, Ross R, Topol EJ. Philadelphia & New York: Lippincott-Raven Publishers; 1995, 1:557-568.
2. Hansson GK: Immune responses in atherosclerosis. In Immune Functions of the Vessel Wall. Edited by Hansson GK, Libby P. Amsterdam: Harwood Academic Publishers; 1996:143-159.
3. Abbas AK, Lichtman AH, Pober JS: Cellular and Molecular Immunology. Philadelphia; WB Saunders Co.: 1994.
4. Janeway CA, Travers P: Immunobiology. The Immune System in Health and Disease, 2nd edn. London: Current Biology Ltd; 1994.
5. Baldwin AS: The NF-kB and IkB proteins: new discoveries and insights. Ann Rev Immunol 1996, 14:649-681. Excellent review of these important transcriptional regulators.
6. Vassalli P: The pathophysiology of tumor necrosis factor. Ann Rev Immunol 1992, 10:411-452.
7. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
8. Bredt DS, Snyder SH: Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem 1994, 63:175-195.
9. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH: Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992, 89:6711-6715.
10. Xie Qw, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan CF: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
11. Geng YJ, Hansson GK, Holme E: Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 1992, 71:1268-1276.
12. Geng YJ, Petersson AS, Wennmalm Å, Hansson GK: Cytokine-induced expression of nitric oxide synthase results in nitrosylation of heme-and non-heme iron proteins in vascular smooth muscle cells. Exp Cell Res 1994, 214:418-428.
13. Yan Z-Q, Yokota T, Hansson GK: Expression of inducible nitric oxide synthase inhibits platelet adhesion to the injured artery. Circ Res 1996, 79:38-44. Proinflammatory cytokines protect the injured artery by inducing NO production.
14. Lanzavecchia A: Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Ann Rev Immunol 1990, 8:145-173.
15. Bentley GA, Mariuzza A: The structure of the T cell antigen receptor. Ann Rev Immunol 1996, 14:563-590.
16. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989, 7:145-173.
17. +T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995, 16:34-38.
18. Gately MK, Desai BB, Wolitsky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizzonite R, Gubler U, Stern AS: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 1991, 147:874-882.
19. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993, 178:1041-1048.
20. Daynes RA, Dowell T, Araneo BA: Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med 1991, 174:1323-1333.
21. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest 1991, 88:904-910.
22. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993, 90:770-774.
23. Kähäri VM, Chen YQ, Su MW, Ramirez F, Uitto J: Tumor necrosis factor-alpha and interteron-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. J Clin Invest 1990, 86:1489-1495.
24. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-beta1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122:103-111.
25. Hansson GK, Hellstrand M, Rymo L, Rubbia L, Gabbiani G: Interferon-γ inhibits both proliferation and expression of differentiation-specific α-smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989, 170:1595-1608.
26. Amento EP, Ehsani N, Palmer H, Libby P: Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991, 11:1223-1230.
27. Zinkernagel RM, Bachmann MF, Kündig TM, Oehen S, Pirchet H, Hengartner, H: On immunological memory. Ann Rev Immunol 1996, 14:333-367. Scholarly review of this enigmatic concept in immunology.
28. Munro JM, van der Walt JD, Munro CS, Chalmers JAC, Cox EL: An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol 1987, 18:375-380.
29. Hansson GK, Seifert PS, Olsson G, Bondjers G: Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb 1991, 11:745-750.
30. + T cells infiltrate lesions of apo E-deficient mice. Am J Pathol 1996, 149:359-366. Immunologic features of atherosclerotic lesions in apoE -/- mice include prominent T-cell infiltration and immune activation.
31. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
32. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK: Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985, 76:125-131.
33. Moyer CF, Sajuthi D, Tulli H, Williams JK: Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol 1992, 138:951-960.
34. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages-implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A 1997, 94:1931-1936. CD40 and its ligand are expressed in atherosclerotic plaques and can be induced in vitro in vascular cells; this suggests a new principle for cell-cell signalling in atherosclerosis.
35. Hansson GK, Holm J, Jonasson L: Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989, 135:169-175.
36. Stemme S, Holm J, Hansson GK: T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992, 12:206-211.
37. van der Wal AC, Das PK, van de Berg DB, van der Loos CM, Backer AE: Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989, 61:166-170.
38. Geng YJ, Holm J, Nygren S, Bruzelius M, Stemme S, Hansson GK: Expression of macrophage scavenger receptor in atherosclerosis. Relationship between scavenger receptor isoforms and the T cell cytokine, interferon-γ. Arterioscler Thromb Vasc Biol 1995, 15:1995-1202.
39. Uyemura K, Demer L, Castle SC, Jullien D, Berliner JA, Gately MK, Warrier RR, Pham N, Fogelman AM, Modlin RL: Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996, 97:2130-2138. Plaque macrophages express IL-12, which promotes IFN-γ secretion by Th1 cells.
40. Poston HN, Haskard DO, Coucher JR, Gall NP, Johnson-Tilney RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992, 140:665-673.
41. Sohma Y, Sasano H, Shiga R, Saeki S, Suzuki T, Nagura H, Nose M, Yamamoto T: Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci U S A 1995, 92:4937-4941.
42. Ylä-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994, 14:32-40.
43. Parums DV, Chadwick DR, Mitchinson MJ: The localization of immunoglobulin in chronic periaortitis. Atherosclerosis 1986, 61:117-123.
44. Kume N, Cybulsky MI, Gimbrone MA: Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992, 90:1138-1144.
45. Gerszten RE, Luscinskas FW, Ding HT, Dichek DA, Stoolman LM, Gimbrone MA, Rosenzweig A: Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro. Circ Res 1996, 79:1205-1215. Memory T-cells preferentially adhere to VCAM-1 expressing endothelial cells under physiological conditions.
46. Sakai M, Miyazaki A, Hakamata H, Sato Y, Matsumura T, Kobori S, Shichiri M, Horiuchi S: Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1996, 16:600-605.
47. Mattsson-Hultén L, Lindmark H, Diczfalusy U, Björkhem I, Ottosson M, Liu Y, Bondjers G, Wiklund O: Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest 1996, 97:461-468. Oxysterols may play a regulatory role in the local lipid metabolism of the plaque.
48. Seifert PS, Kazatchkine MD: Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position. Mol Immunol 1987, 24:1303-1308.
49. Torzewski J, Oldroyd R, Lachmann P, Fitzsimmons C, Proudfoot D, Bowyer D: Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells-a possible initiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 1996, 16:673-677. Complement, which is activated by oxidized lipids in the intima, can induce smooth muscle cells to recruit monocytes via secretion of the chemoattractant monocyte chemotactic protein-1.
50. Muller K, Hardwick SJ, Marchant CE, Law NS, Waeg G, Esterbauer H, Carpenter KLH, Mitchinson MJ: Cytotoxic and chemotactic potencies of several aldehydic components of oxidised low density lipoprotein for human monocyte-macrophages. FEBS Lett 1996, 388:165-168.
51. Björkerud B, Björkerud S: Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth vs. apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol 1996, 16:416-424.
52. Ohlsson BG, Englund MCO, Karlsson ALK, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappa B to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1 beta in macrophages. J Clin Invest 1996, 98:78-89. Ox-LDL may play a regulatory role in inflammation by modulating NF-κB.
53. ••].
54. ••] demonstrate how NO can regulate immune-dependent vascular events on the transcriptional level.
55. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Cartiss LK, Witcham J: Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996, 98:800-814. Identification of B-cell epitopes on Ox-LDL.
56. Mironova M, Virella G, Lopes-Virella MF: Isolation and characterisation of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol 1996, 16:222-229.
57. Holvoet P, Perez G, Zhao Z, Brouwers E, Bernar H, Collen D: Malondialdehyde-modified low density lipoprotein in patients with atherosclerotic disease. J Clin Invest 1995, 95:2611-2619.
58. Hörkkö S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996, 98:815-825. Antibodies to phospholipids recognize oxidized molecules, supporting the idea that oxidation breaks tolerance.
59. Nityanand S, Bergmark C, de Faire U, Swedenborg J, Holm G, Lefvert AK: Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med 1995, 238:437-443.
60. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssänen K, Palinski W, Witztum JL: Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992, 339:883-887.
61. Uusitupa MIJ, Niskanen L, Luoma J, Vilja P, Mercuri M, Rauramaa R, Ylä-Herttuala S: Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16:1236-1242.
62. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized LDL. Proc Natl Acad Sci U S A 1995, 92:3893-3897. Identification of immunologic specificity of T-cells in human plaques.
63. Geng Y-J, Hansson GK: High endothelial cells of postcapillary venules express the scavenger receptor in human peripheral lymph nodes. Scand J Immunol 1995, 42:289-296.
64. Fraser I, Hughes D, Gordon S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 1993, 364:343-346.
65. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T et al.: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386:292-296. Scavenger receptors are pro-atherogenic but important in the host defence.
66. Kiessling R, Grönberg A, Ivanyi J, Sîderstrîm K, Ferm M, Kleinau S, Nilsson E, Klareskog L: Role of hsp60 during autoimmune and bacterial inflammation. Immunol Rev 1991, 121:91-111.
67. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G: Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein. J Clin Invest 1993, 91:2693-2702.
68. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993, 341:255-259.
69. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufmann S, Wick G: Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992, 12:789-799.
70. Xu Q, Wick G: The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today 1996, Sept:372-379. Provocative review on hsp60 as an athero-antigen.
71. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 1995, 16:27-33.
72. Yamashiroya HM, Ghosh L, Yang R, Robertson AL: Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988, 130:71-79.
73. Hajjar DP, Fabricant CG, Minick CR, Fabricant J: Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 1986, 122:62-69.
74. Hendrix MGR, Dormans PHJ, Kitslaar P, Bosman F, Bruggeman CA: The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 1989, 134:1151-1157.
75. Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE: Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest 1996, 98:2129-2138.
76. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996, 335:624-630. Possible role of CMV or anti-CMV immune responses, or both, in restenosis.
77. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M: Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996, 94:922-927. Identification of the virus as a risk factor for atherosclerosis.
78. Puolakkainen M, Kuo CC, Shor A, Wang SP, Grayston JT, Campbell LA: Serological response to Chlamydia pneumonias in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol 1993, 31:2212-2214.
79. Kuo CC, Gown AM, Benditt EP, Grayston JT: Detection of Chlamydia pneumonias in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993, 13:1501-1504.
80. Blasi F, Ranzi ML, Erba M, Tarsia P, Raccanelli R, Fagetti L, Allegra L: No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. Atherosclerosis 1996, 126:339-340.
81. Breslow JL: Mouse models of atherosclerosis. Science 1996, 272:685-688. Review of available murine models of atherosclerosis.
82. Curtiss LK, Edgington TS: Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. J Clin Invest 1978, 61:1298-1308.
83. Brand K, Mackman N, Curtiss LK: Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. J Clin Invest 1993, 91:2031-2039.
84. Roselaar SE, Kakkanathu PX, Daugherty A: Lymphocyte populations in atherosclerotic lesions of apo E -/- and LDL receptor -/-mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996, 16:1013-1018. T-cells are particularly frequent in early phases of atherosclerosis in apoE-0 mice.
85. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995, 91:2844-2850.
86. Shah PK, Falk E, Badimon JJ, Fernandez OA, Mailhac A, Villareal LG, Fallon JT, Regnstrom J, Fuster V: Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995, 92:1565-1569.
87. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT: Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994, 90:775-778.
88. Davies MJ: Stability and instability: two faces of coronary atherosclerosis. Circulation 1996, 94:2013-2020. Review of plaque rupture with emphasis on biomechanical and proteolytic aspects.
89. Kaartinen M, Penttila A, Kovanen PT: Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α. Circulation 1996, 11:2787-2792.
90. Kovanen PT, Kaartinen M, Paavonen T: Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92:1084-1088. This paper suggests that (Th2-dependent) mast cell activation is important for plaque rupture.
91. van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
92. Geng Y-J, Wu Q, Muszynski M, Hansson GK, Libby P: Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α and interleukin-1β. Arterioscl Thromb Vasc Biol 1996, 16:19-27. Th1-type and proinflammatory cytokines can induce apoptosis in smooth muscle cells.
93. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnarable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
94. Galis ZS, Muszynski M, Sukhova GK, Simon ME, Unemori EN, Lark MW, Amento E, Libby P: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994, 75:181-189.
95. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S: Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 1991, 88:8154-8158.
96. Sarén P, Welgus HG, Kovanen PT: TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996, 157:4159-4165. Counterbalancing role of proinflammatory cytokines (TNF-α, IL-1β) and IFN-γ in regulating matrix metalloproteinase secretion.
97. Caligiuri G, Summaria F, Liuzzo G, Maseri A: Time course of T-lymphocyte activation and of C-reactive protein in unstable angina: relation to prognosis. Circulation 1996, 94(suppl 1):I-571.
98. Buttery LDK, Springall DR, Chester AH, Evans TJ, Standfield N, Parums DV, Yacoub MH, Polak JM: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996, 75:77-85. Cytokine-inducible NO synthase is expressed and active in the plaque.
99. Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm Å, Jennische E: Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med 1994, 180:733-738.
100. Roselaar SE, Schonfeld G, Daugherty A: Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest 1995, 96:1389-1394. Cyclosporin A aggravates atherosclerosis in rabbits, suggesting that cell-mediated immunity inhibits disease progression.
101. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M: Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 1995, 92:8264-8268. Evidence for pro-atherogenic role of macrophages.
102. Fyfe AI, Qiao JH, Lusis AJ: Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 1994, 94:2516-2520.
103. Hansson GK, Holm J, Holm S, Fotev Z, Hedrich HJ, Fingerle J: T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci U S A 1991, 88:10530-10534.
104. Palinski W, Miller E, Witztum JL: Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A 1995, 92:821-825. Evidence for a beneficial effect of 'vaccination' with Ox-LDL in experimental atherosclerosis.
105. Ameli S, Hultgardh-Nilsson A, Regnström J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J: Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 1996, 16:1074-1079. Beneficial effect of immunization with Ox-LDL in a diet-induced model.
106. Jonasson L, Holm J, Hansson GK: Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci U S A 1988, 85:2303-2306.
107. Thyberg J, Hansson GK: Cyclosporine A inhibits induction of DNA synthesis by PDGF and other peptide mitogens in cultured rat aortic smooth muscle cells and dermal fibroblasts. Growth Factors 1991, 4:209-219.
108. Lemström KB, Raisanen-Sokolowski AK, Häyry PJ, Koskinen PK: Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1996, 16:553-564. Effect of immunosuppressive treatment supports immunologic aetiology of transplant arteriosclerosis.
109. + cells or natural killer cells) in transplant arteriosclerosis.
110. Russell PS, Chase CM, Winn HJ, Colvin RB: Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994, 152:5135-5141.